Obalon Therapeutics prices $35m offering

From Medical Design & Outsourcing

• May 2018 issue: DeviceTalks Minnesota Show preview, the hottest medtech startups of 2018 and more.
  Minnesota continues to attract medtech innovators California, especially Silicon Valley, may have a reputation as an epicenter of digital health. But while researching the health of the Minnesota medtech hub, I came to an important realization: There is actually a lot going on in the North Star State. Here’s just a sample of the recent […]
• Fermatex returning to familiar Adam Spence name
  Fermatex Vascular Technologies (Wall, N.J.) — formerly WL Gore Jersey Shore and most notably Adam Spence — said today that it is rebranding back to the Adam Spence name. The name change will be effective June 4. Company officials said that going back to the Adam Spence name will help the company benefit from Adam Spence’s […]
• How 3D printing is boosting cancer treatment
  Radiologists are creating patient-specific, life-sized 3D printed models to show the location of tumors in bones, organs, nerves and blood vessels. The 3D printing method could help doctors plan treatments for different types of cancers and tumors. In the past, 3D printing has been a valuable tool for clinicians to plan surgeries and make implants […]
• This tattoo-like sensor measures blood glucose levels non-invasively
  Diabetes tracking can be a scary and tedious task, but University of California at San Diego researchers have developed a needless glucose monitor tattoo sensor that measures insulin levels through sweat on the skin. There are approximately 30.3 million people living with diabetes in the U.S., according to the American Diabetes Association. Monitoring blood sugar […]
• 6 reasons you shouldn’t bet on blockchain disrupting healthcare
  Blockchain is the big buzzword these days, bruited as a disruptive force for industries covering the spectrum. But there seems to be little understanding of what exactly “blockchain” means, let alone how it could affect so many different markets so profoundly. Simply put, a blockchain is a decentralized database with tight rules about how data […]
• How SABIC helped develop a non-drug migraine treatment
  SABIC recently helped eNeura develop a clinically proven, non-drug option for preventing and treating migraine headaches. The sTMS mini from eNeura is a portable delivery system for single-pulse, transcranial magnetic stimulation. It’s prescribed by a physician. FDA cleared the sTMS mini for migraine prevention in 2017. SABIC’s polycarbonate copolymer Lexan was chosen as the housing of […]
• 8 companies commercializing transcatheter mitral valve replacements
  Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used […]
• 4 ways medtech contractors are evolving (and why)
  The present and near future for medtech contractors will rely on specific strategies such as tiered partnerships and consolidation, an emphasis on speed, and owning therapeutic and technology spaces.  Andrew Potter, Bonifacio Consulting Services, and Christopher Delporte In the first article in this series, we examined some of the important trends during the last 10–15 years […]
• Minnesota’s Medical Alley has a big presence at EuroPCR
  The Medical Alley Association in Minnesota is touting the major presence that companies and organizations from the state will have at this year’s EuroPCR, which is being held this week in Paris. The event — the European Association of Percutaneous Cardiovascular Interventions’ annual meeting — is May 22–25 at the Palais des Congrès and is expected to […]
• Will FDA turn to neuroscience-based human factors research?
  There is a new wind blowing in medical technology — one that many believe is overdue: an overhaul of human factors. At the recent Patient Safety Initiative, Charles Murphy, Chief Patient Safety Officer at the Inova Heart and Vascular Institute, called out human factors as one of the key factors he believed needed to be […]
• High-volume manufacturing: Essential points to consider before you scale up
  High-volume manufacturing typically involves the introduction of automation into the medical device fabrication and assembly process. A number of benefits usually follow: repeatability, heightened quality and lower (and more predictable) long-term costs of operation. Download the B. Braun Medical white paper. The post High-volume manufacturing: Essential points to consider before you scale up appeared first […]